Darafenib
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Darafenib, covering 2025-06-15 to 2025-06-15. Get the full timeline:
Most recent: Clinical Trial Update: Real-world Study of Darafenib or Trametinib and Clofarabine for High-risk/Recurrent/Refractory Langerhans Cell Histiocytosis in Children [Phase 2]